Evommune (EVMN) Non-cash Items (2024 - 2026)

Evommune (EVMN) has 3 years of Non-cash Items data on file, last reported at $92.0 million in Q1 2026.

• Quarterly Non-cash Items changed N/A year-over-year to $92.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92.0 million (changed N/A YoY) and the FY2025 annual result came in at $54.5 million, up 9216.75% from the prior year.
• Non-cash Items grew to $92.0 million in Q1 2026 per EVMN's latest filing, from $54.5 million in the prior quarter.
• Across five years, Non-cash Items topped out at $92.0 million in Q1 2026 and bottomed at $585000.0 in Q4 2024.
• The 3-year median for Non-cash Items is $30.7 million (2025), against an average of $38.5 million.
• Peak annual rise in Non-cash Items reached 9216.75% in 2025, while the deepest fall reached 9216.75% in 2025.
• Tracing EVMN's Non-cash Items over 3 years: stood at $585000.0 in 2024, then surged by 9216.75% to $54.5 million in 2025, then soared by 68.75% to $92.0 million in 2026.
• Per Business Quant, the three latest EVMN Non-cash Items figures stand at $92.0 million (Q1 2026), $54.5 million (Q4 2025), and $6.9 million (Q3 2025).

Peer Comparison